24 November 2017, Friday, Afternoon |
|
Bernard Roizman 伯纳德•罗兹曼 Topic: The Evolution of Herpes Simplex Viruses as Oncolytic Agents 题目: 单纯疱疹病毒作为溶瘤细胞制剂的演化 Honorary Chairman, Shenzhen International Institute for Biomedical Research (SIIBR) 深圳罗兹曼国际转化医学研究院荣誉院长
Professor, Chicago University, USA美国芝加哥大学资深教授
Academician, Academy of Sciences, Medical College and Inventor Academy of Sciences, USA美国科学院，医学院，发明家学院三院院士
Foreign Academician, Chinese Academy of Engineering中国科学院工程院外籍院士
“Father of Herpes Virus”, world-authority figure in Oncolytic Herpes Virus国际病毒领域泰斗－“疱疹病毒之父” •溶瘤疱疹病毒世界权威 |
Symposium - Cancer Immunotherapy
(Sponsored by Shenzhen International Institute for Biomedical Research [SIIBR]) 癌症的免疫疗法（深圳罗兹曼国际转化医学研究院赞助） Shenzhen
International Institute for Biomedical Research (SIIBR), established
since January 2015, is led by Professor Benard Roizman. The research
focus of SIIBR is in cancer and acute and chronic microbial infection. 深圳罗兹曼国际转化医学研究院（The
Shenzhen International Institute for Biomedical Research,
SIIBR）于2015年1月注册成立，研究院由伯纳德•罗兹曼（Bernard•Roizman）教授领衔。
研究院以肿瘤和急慢性微生物感染治疗为重点研究领域。 |
| Moderator: Grace Zhou 周国瑛 Director, Shenzhen International Institute of Biomedical Research, China 深圳罗兹曼国际转化医学研究院院长
Ph.D. Shanghai Institute of Biochemistry, Chinese Academy of Sciences 中国科学院上海生物化学研究所博士
CEO, ImmVira Co., Ltd., Shenzhen, China 深圳市亦诺微医药有限公司首席执行官
Director, Institute of Genome and Drug Quality, Beijing Institute of Biotechnology Industry 北京亦创生物技术产业研究院基因药物质量研究所所长
Distinguished Professor, State Key Laboratory of Respiratory Diseases, Guangzhou Medical University 广州医科大学呼吸病国家重点实验室特聘教授
Former Associate Professor, Department of Microbiology, University of Chicago, USA 前美国芝加哥大学微生物系副教授
|
| Xiao-Yan Dong 董小岩 Topic: Overview of viral vectors used for gene therapy 题目: 用于基因治疗的病毒载体概述 Founder, Beijing FivePlus Molecular Medicine Institute Co. Ltd.(5+MMI) 北京五加和分子医学研究所有限公司创始人
Director, Department of Molecular Medicine, Beijing Institute of Biotechnology Industry 北京亦创生物技术产业研究院分子医学研究所所长
Zhongguancun Park Leading Talent ”中关村领军人才”
Beijing E-Town Talents, Innovative and Entrepreneur Talents Project “新创工程•亦麒麟领军人才”
|
| Yi-Jing He 贺毅憬 Topic: Cancer Immunotherapy - Challenges and Solutions of Companion Diagnosis 题目: 癌症免疫治疗 - 伴隨式診斷的挑战和解决方案 Associate Professor, Moffitt Cancer Center, USA 美国墨菲特癌症中心副教授
Chairman, Shenzhen INDA Biotechnology Co. Ltd. 深圳因答生物科技有限公司 董事长
|
| Xiao Shen 沈潇 Topic: Next Generation Animal Cell Culture Bioreactor for Scalable Recombinant Protein Expression 题目：用于可扩展重组蛋白表达的下一代动物细胞培养生物反应器 Founder, Chairman, Cantonbio Ltd, Guangzhou 广州汉腾生物科技有限公司创始人董事长
Member, European Animal Cell Engineering Association and the Asian Animal Cell Engineering Association 欧洲动物细胞工程协会及亚洲动物细胞工程协会会员
中国侨联创业联盟理事
广州市开发区创业英才”
“广东省珠江人才计划引进创新团队带头人”
|
| Chun-Lin Chen 陈春麟 Topic:
Strategies and Concerns for the Preclinical Assessment and Submission
of Drugs that meet dual compliants of US FDA and Chinese FDA 题目: 符合中美FDA双报要求的药物临床前评估及申报的策略和关注点 CEO, Shanghai Medicilon Inc. 上海美迪西生物医药股份有限公司首席执行官
|
| James Xue-Jun Cai 蔡学钧 Topic: New Era of Biopharma in China - New Opportunity and Challenge in MRCT 题目: 中国生物制药新时代 - MRCT新机遇与挑战 Director, Global Regulatory Affairs for JAPAC, Amgen Inc. 安进公司日本及亚太地区药政事务总监
|
| Da-Jie Tang 汤大杰 Topic: Biomedical Investment- Our Logic and Method 题目: 生物医药投资 : 我们的逻辑和做法 Founding Partner, Triwise Capital Management Ltd., Shenzhen 深圳前海勤智国际资本管理有限公司创始合伙人总裁
Executive Vice President, Shenzhen Science and Technology Entrepreneurship Promotion Association 深圳市科技创业促进会常务副理事长
Adjunct
Professor, Southwestern University of Finance and Economic, Guangdong
University of Finance & Economic, Shenzhen Audencia Business School,
Xidian University, China University of Mining and Technology
西南财经大学、广东财经大学、深圳南特商学 院、西安电子科技大学，中国矿业大学兼职教授
|
Evening 晚上 |
Gala Dinner cum GuangDong - Hong Kong - Macao Greater Bay Area Alliance Inauguration Ceremony 晚宴暨粤港澳大湾区生物科技联盟成立仪式 |
